The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 27, 2025

Filed:

Jan. 25, 2022
Applicant:

Noctrix Health, Inc., San Francisco, CA (US);

Inventors:

Jonathan David Charlesworth, San Francisco, CA (US);

Shriram Raghunathan, Castro Valley, CA (US);

Assignee:

NOCTRIX HEALTH, INC., Pleasanton, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61B 5/00 (2006.01); A61B 5/024 (2006.01); A61B 5/0531 (2021.01); A61B 5/08 (2006.01); A61B 5/11 (2006.01); A61N 1/04 (2006.01); A61N 1/05 (2006.01); A61N 1/08 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36057 (2013.01); A61B 5/0531 (2013.01); A61B 5/4082 (2013.01); A61B 5/4836 (2013.01); A61N 1/08 (2013.01); A61N 1/36 (2013.01); A61N 1/36014 (2013.01); A61N 1/36031 (2017.08); A61N 1/36034 (2017.08); A61N 1/36067 (2013.01); A61N 1/36139 (2013.01); A61N 1/3614 (2017.08); A61N 1/3615 (2013.01); A61N 1/36167 (2013.01); A61B 5/0022 (2013.01); A61B 5/02405 (2013.01); A61B 5/08 (2013.01); A61B 5/1114 (2013.01); A61B 5/1116 (2013.01); A61B 5/4809 (2013.01); A61B 5/4815 (2013.01); A61B 5/7264 (2013.01); A61B 5/7475 (2013.01); A61B 2562/0219 (2013.01); A61N 1/0456 (2013.01); A61N 1/0476 (2013.01); A61N 1/0484 (2013.01); A61N 1/0492 (2013.01); A61N 1/0556 (2013.01); A61N 2001/083 (2013.01); A61N 1/36021 (2013.01); A61N 1/36071 (2013.01); A61N 1/36078 (2013.01);
Abstract

Techniques to help improve efficiency or effectiveness of treating a disorder such as RLS or PLMD, such as by issuing neural electrostimulations to a particular patient, while varying one or more amplitude parameters (e.g., at least one of electrostimulation current amplitude, electrostimulation voltage amplitude, or electrostimulation pulsewidth duration). A corresponding patient-subjective or patient-objective response can be observed. A characteristic electrostimulation intensity relationship can be generated, for example, based on the determined respective at least one of RLS or PLMD response indication threshold amplitude parameters and the plurality of corresponding neural electrostimulation durations. Once this characteristic electrostimulation intensity relationship has been generated, it can then be used to control issuing subsequent neural electrostimulations to the particular patient according to (1) at least one goal and (2) a variable operating point based upon the generated characteristic electrostimulation intensity relationship.


Find Patent Forward Citations

Loading…